Results 51 to 60 of about 68 (65)
Some of the next articles are maybe not open access.
PP146 Cost-Effectiveness Of Nivolumab Plus Ipilimumab In Advanced Melanoma
International Journal of Technology Assessment in Health Care, 2018Introduction:This study was done to assess the cost effectiveness of nivolumab plus ipilimumab (NIV+IPI) versus nivolumab alone (NIV) for previously untreated patients with advanced melanoma (AM) from the Dutch health system perspective.Methods:A Markov model was constructed with a lifetime horizon.
openaire +1 more source
PP146-SUN: Inflammatory Bowel Disease and Compliance with the Mediterranean Diet
Clinical Nutrition, 2014V. Teixeira +3 more
openaire +1 more source

